Diferencia entre revisiones de «Harbor:Sepsis antibiotics»

(Text replacement - "0 mg" to "0mg")
Línea 35: Línea 35:
*'''Hospitalized ward patients (PORT III):'''  
*'''Hospitalized ward patients (PORT III):'''  
**[[Beta-lactam]] + [[macrolide]] OR [[doxycycline]] ([[quinolone]] ok, but save for sick pt):  
**[[Beta-lactam]] + [[macrolide]] OR [[doxycycline]] ([[quinolone]] ok, but save for sick pt):  
***'''[[Ceftriaxone]] '''1 gm IV Qday + '''[[Azithromycin]] '''500 mg IV Qday OR '''[[Doxycycline]] '''100mg IV BID  
***'''[[Ceftriaxone]] '''1 gm IV Qday + '''[[Azithromycin]] '''500mg IV Qday OR '''[[Doxycycline]] '''100mg IV BID  
***If cephalosporin allergy:  
***If cephalosporin allergy:  
****'''[[Moxifloxacin]] '''400 mg IV Qday OR '''[[Levofloxacin]] '''750mg IV Qday  
****'''[[Moxifloxacin]] '''400mg IV Qday OR '''[[Levofloxacin]] '''750mg IV Qday  
*'''PCU/ICU patients with out RF for [[Pseudomonas]] or [[MRSA]]:'''  
*'''PCU/ICU patients with out RF for [[Pseudomonas]] or [[MRSA]]:'''  
**[[Beta-lactam]] + [[macrolide]] OR [[Quinolone]] (Save for sick patients if possible). [[Quinolone]] monotheraphy not acceptable for these patients:  
**[[Beta-lactam]] + [[macrolide]] OR [[Quinolone]] (Save for sick patients if possible). [[Quinolone]] monotheraphy not acceptable for these patients:  
***'''[[Ceftriaxone]] '''1 gm IV Qday + '''[[Azithromycin]] '''500 mg IV Qday OR '''[[Levofloxacin]] '''750mg IV Qday  
***'''[[Ceftriaxone]] '''1 gm IV Qday + '''[[Azithromycin]] '''500mg IV Qday OR '''[[Levofloxacin]] '''750mg IV Qday  
*'''PCU/ICU patients w/RF for [[Pseudomonas]]:'''  
*'''PCU/ICU patients w/RF for [[Pseudomonas]]:'''  
**'''[[Cefepime]] '''2g IV Q8H + '''[[Levofloxacin]] '''750mg IV Qday
**'''[[Cefepime]] '''2g IV Q8H + '''[[Levofloxacin]] '''750mg IV Qday
Línea 55: Línea 55:
***Add '''[[Meropenem]]'''  
***Add '''[[Meropenem]]'''  
*[[Cephalosporin]] allergy:  
*[[Cephalosporin]] allergy:  
**[[Clinda]] 600 mg IV  
**[[Clinda]] 600mg IV  
**[[Cipro]] 400 mg IV  
**[[Cipro]] 400mg IV  
**[[Gentamicin]] 5-7 mg/kg IV
**[[Gentamicin]] 5-7 mg/kg IV


Línea 69: Línea 69:
**[[Metronidazole]] 1.5 mg IV
**[[Metronidazole]] 1.5 mg IV
*Cephalosporin allergy           
*Cephalosporin allergy           
**[[Cipro]] 400 mg IV
**[[Cipro]] 400mg IV
**[[Metronidazole]] 1.5 g IV
**[[Metronidazole]] 1.5 g IV
**[[Gentamicin]] 5-7 mg/kg IV
**[[Gentamicin]] 5-7 mg/kg IV
Línea 83: Línea 83:
*Cephalosporin allergy           
*Cephalosporin allergy           
**[[Vancomycin]] 1g IV
**[[Vancomycin]] 1g IV
**[[Cipro]] 400 mg IV
**[[Cipro]] 400mg IV
**[[Gentamicin]] 5 mg/kg IV
**[[Gentamicin]] 5 mg/kg IV


Línea 120: Línea 120:
**[[Vancomycin]] 1 gm IV
**[[Vancomycin]] 1 gm IV
**[[Ceftriaxone]] 1 gm IV
**[[Ceftriaxone]] 1 gm IV
**[[Clinda]] 600 mg IV
**[[Clinda]] 600mg IV
**Consider: Gent 5-7mg/k IV
**Consider: Gent 5-7mg/k IV
*Healthcare Assoc.           
*Healthcare Assoc.           
Línea 128: Línea 128:
*Cephalosporin allergy           
*Cephalosporin allergy           
**[[Vancomycin]] 1 gm IV
**[[Vancomycin]] 1 gm IV
**[[Clinda]] 600 mg IV
**[[Clinda]] 600mg IV
**[[Cipro]] 400 mg IV
**[[Cipro]] 400mg IV
**[[Gentamicin]] 5-7mg/kg
**[[Gentamicin]] 5-7mg/kg



Revisión del 01:17 19 jul 2016

Unknown Source[1]

Pneumonia

Community Acquired Pneumonia (CAP)

MCC by S. pneumoniae. In young must cover for mycoplasma and other atypicals. See Pneumonia (Pathogens)

Treatment based on Pneumonia (Port Score)

Healthcare Associated PNA (HCAP) + Hospital Associated PNA (HAP)

HAP occurs if patient develops PNA 2-3 days after hospitalization. HCAP occus in non-hospitalized patient with extensive healthcare contact.

Abdominal/Pelvic

Urosepsis

Meningitis (Nl/Community)

Meningitis (Nl/Post neurosurgical)

Meningitis (Immunocomp)

(Cirrhosis, EtoH, age > 65, steroids, HIV)

Necrotizing Soft-tissue Infection

Neutropenic Fever

  • Severe Sepsis
    • Cefepime 2 g IVPB x 1
    • Vancomycin 1 g IVPB x 1
  • Septic Shock

See Also

Harbor:Antibiotics by diagnosis

See also Harbor: Sepsis core measures
Initial Antibiotics in Sepsis (Main)

References

  1. Form v2011.09.15